Mylan, Watson to ship antihypertensive generics
Mylan Inc. and Watson Pharmaceuticals Inc. have received approval from the Food and Drug Administration for generic versions of medications for hypertension. Mylan said Friday that its Mylan Pharmaceuticals Inc. subsidiary obtained clearance for the generic versions of Hyzaar Tablets (50 mg/12.